Dr. Steven Shih-Wei Chang, MD

Dr. Chang practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Chang's NPI, 1407994494, was assigned on February 2, 2007. Dr. Chang graduated from The Johns Hopkins University School of Medicine in 2005. Dr. Chang holds Michigan license 4301102319.

Dr. Chang's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.

Dr. Chang's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Chang is also affiliated with Henry Ford Macomb Hospital. The medical group on file is Henry Ford Health. Dmand AI also links Dr. Chang to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Chang's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Chang is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Chang is licensed in Michigan.

CMS data shows 155 Medicare services from Dr. Chang across 3 procedure codes in 2024, for 75 Medicare patients. Medicare paid $7,691 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 75 Medicare patients who saw Dr. Chang in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chang's median patient age at 70, with 44% women.

In 2024, Dr. Chang wrote 108 Medicare Part D claims for 38 patients. 91% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $46 in total drug cost. In 2023, CMS named 56 claims across 3 drugs.

Dr. Chang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chang as offering telehealth.

Dmand AI links 77 papers to Dr. Chang, published from 2007 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Cell Line, Tumor. Dr. Chang has published most often in Head Neck. Dr. Chang's most frequent co-authors are Joseph A. Califano, MD, Tamer A. Ghanem, MD and Farzan Siddiqui, MD, PhD.

Dmand AI links Dr. Chang to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Head and Neck Neoplasms.

CMS Open Payments shows 14 general payments to Dr. Chang from 6 drug and device companies from 2016 to 2024. Honoraria make up the largest share, 56% of the total. Concordia Laboratories Inc. paid the most, $2,057.

Dmand AI lists 1 award for Dr. Chang, most recently CMS Stage 1 EHR in 2013.

Dr. Chang graduated from The Johns Hopkins University School of Medicine in 2005.

Dr. Chang is in network with 10 carriers, including Health Alliance Plan, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.